Balance Sheets
Condolidated Balance Sheets
(Billions of yen)
(Millions of yen)
YEARS ENDED MARCH 31 |
2020/3 |
2021/3 |
2022/3 |
2023/3 |
2024/3 |
Assets |
Current assets: |
595,692 |
629,207 |
681,981 |
713,553 |
763,072 |
- Cash and time deposits |
64,073 |
76,546 |
92,966 |
84,700 |
66,186 |
- Notes and accounts receivable, trade |
294,504 |
319,644 |
357,341 |
388,499 |
430,128 |
- Inventories |
188,113 |
183,190 |
170,295 |
198,691 |
226,135 |
- Other current assets |
49,001 |
49,826 |
61,378 |
41,662 |
40,620 |
Long-term assets: |
401,016 |
422,652 |
435,058 |
467,946 |
508,064 |
- Tangible fixed assets |
201,892 |
209,758 |
233,675 |
283,912 |
311,456 |
- Intangible fixed assets |
24,606 |
23,426 |
22,504 |
24,032 |
25,462 |
- Investments and other assets |
174,517 |
189,468 |
178,878 |
160,001 |
171,145 |
Deferred assets |
118 |
92 |
71 |
51 |
37 |
Total assets |
996,827 |
1,051,952 |
1,117,112 |
1,181,552 |
1,271,174 |
Liabilities and shareholders' equity |
Current liabilities: |
423,160 |
356,416 |
386,969 |
446,826 |
475,342 |
- Notes and accounts payable, trade |
179,914 |
167,260 |
171,749 |
201,593 |
207,408 |
- Short-term loans |
21,342 |
21,744 |
44,984 |
46,875 |
40,259 |
- Current portion of debentures |
15,000 |
- |
- |
15,000 |
- |
- Other current liabilities |
206,903 |
167,411 |
170,236 |
183,357 |
227,674 |
Long-term liabilities |
167,664 |
234,281 |
206,413 |
162,657 |
134,359 |
- Long-term debt and bonds |
73,604 |
131,686 |
101,276 |
48,600 |
35,100 |
- Net defined benefit liability |
50,011 |
53,322 |
57,590 |
60,345 |
63,803 |
- Other long-term liabilities |
44,048 |
49,272 |
47,545 |
53,711 |
35,455 |
Total liabilities |
590,825 |
590,698 |
593,382 |
609,483 |
609,701 |
Net Assets |
Shareholders' equity: |
327,513 |
358,021 |
405,467 |
451,091 |
509,278 |
- Common stock |
47,586 |
47,586 |
47,586 |
47,586 |
47,586 |
- Capital surplus |
45,949 |
46,003 |
45,955 |
45,953 |
45,954 |
- Retained earnings |
241,305 |
271,772 |
319,285 |
364,922 |
423,135 |
- Treasury stock at cost |
-7,327 |
-7,340 |
-7,359 |
-7,370 |
-7,397 |
Valuation and translation adjustments: |
38,105 |
58,975 |
67,433 |
66,000 |
93,237 |
- Unrealized gain on other securities |
44,606 |
55,761 |
51,649 |
45,550 |
54,717 |
- Deferred gain on hedges |
-231 |
322 |
507 |
241 |
-35 |
- Foreign currency transaction adjustment |
-3,545 |
1,539 |
14,169 |
22,222 |
37,772 |
- Remeasurements of defined benefit plans |
-2,724 |
1,351 |
1,107 |
-2,013 |
782 |
Minority interests in consolidated subsidiaries |
3,078 |
3,415 |
5,894 |
7,285 |
6,717 |
Total net assets |
406,002 |
461,254 |
523,729 |
572,068 |
661,472 |
Total liabilities and net assets |
996,827 |
1,051,952 |
1,117,112 |
1,181,552 |
1,271,174 |
Income Statement / Statement of Comprehensive Income
Consolidated Statements of Income
(Billions of yen)
(Millions of yen)
YEARS ENDED MARCH 31 |
2020/3 |
2021/3 |
2022/3 |
2023/3 |
2024/3 |
Net sales |
900,604 |
875,927 |
910,226 |
1,009,447 |
1,103,214 |
Cost of sales |
680,067 |
654,661 |
657,789 |
732,528 |
799,925 |
- Gross profit |
220,536 |
221,266 |
252,436 |
276,918 |
303,289 |
- Ratio to net sales (%) |
24.5 |
25.3 |
27.7 |
27.4 |
27.5 |
Selling, general and administration |
178,020 |
172,670 |
177,601 |
188,036 |
197,222 |
- Operating income (loss) |
42,515 |
48,595 |
74,835 |
88,882 |
106,066 |
- Ratio to net sales (%) |
4.7 |
5.5 |
8.2 |
8.8 |
9.6 |
Non-operating income |
5,505 |
5,951 |
7,329 |
5,927 |
7,903 |
- Interest and dividends received |
2,830 |
2,955 |
2,885 |
3,742 |
3,346 |
- Other |
2,674 |
2,995 |
4,444 |
2,185 |
4,557 |
Non-operating expenses |
3,507 |
4,146 |
2,867 |
6,997 |
6,147 |
- Interest expense |
1,405 |
1,441 |
1,744 |
1,993 |
2,101 |
- Other |
2,102 |
2,704 |
1,122 |
5,004 |
4,046 |
- Ordinary income (loss) |
44,513 |
50,401 |
79,297 |
87,811 |
107,822 |
- Ratio to net sales (%) |
4.9 |
5.8 |
8.7 |
8.7 |
9.8 |
Extraordinary income |
2,771 |
41,145 |
10,538 |
11,154 |
8,554 |
Extraordinary loss |
3,423 |
28,262 |
1,349 |
3,220 |
2,344 |
- Income before income taxes |
43,860 |
63,284 |
88,487 |
95,746 |
114,032 |
- Income taxes and business tax (%) |
4.9 |
7.2 |
9.7 |
9.5 |
10.3 |
Income taxes and business tax |
12,488 |
21,423 |
21,846 |
26,317 |
32,118 |
Deferred income taxes |
-499 |
-3,481 |
2,085 |
794 |
-156 |
Income before minority interests |
31,871 |
45,342 |
64,555 |
68,634 |
82,070 |
Profit attributable to non-controlling interests |
3,078 |
3,415 |
5,894 |
7,285 |
6,717 |
- Profit (loss) attributable to owners of parent |
28,793 |
41,926 |
58,660 |
61,348 |
75,353 |
- Ratio to net sales (%) |
3.2 |
4.8 |
6.4 |
6.1 |
6.8 |
Consolidated Statements of Comprehensive Income
(Millions of yen)
YEARS ENDED MARCH 31 |
2020/3 |
2021/3 |
2022/3 |
2023/3 |
2024/3 |
Income before minority interests |
31,871 |
45,342 |
64,555 |
68,634 |
82,070 |
Other comprehensive income (loss) |
Valuation differences on available-for-sale securities |
608 |
11,400 |
-4,222 |
-6,202 |
8,871 |
Deferred gains or loss on hedges |
49 |
553 |
185 |
-265 |
-277 |
Foreign currency translation adjustments |
-4,574 |
5,935 |
13,985 |
8,176 |
16,456 |
Remeasurements of defined benefit plans net of tax |
-1,531 |
4,419 |
-37 |
-3,279 |
2,804 |
Share of other comprehensive income (loss) of associates accounted for using equity method |
402 |
-215 |
20 |
54 |
432 |
Total other comprehensive loss |
-5,046 |
22,094 |
9,930 |
-1,516 |
28,288 |
Comprehensive income (loss) |
26,825 |
67,437 |
74,485 |
67,117 |
110,358 |
Comprehensive income (loss) Attributable to: |
Comprehensive income attributable to owners of parent |
24,254 |
62,796 |
67,118 |
59,915 |
102,590 |
Comprehensive income attributable to non-controlling interests |
2,570 |
4,640 |
7,367 |
7,202 |
7,768 |
Cash Flows
Consolidated Statements of Cash Flows
(Billions of yen)
(Millions of yen)
YEARS ENDED MARCH 31 |
2020/3
| 2021/3
| 2022/3
| 2023/3
| 2024/3
|
Cash flows from operating activities: |
Income (loss) before income taxes |
43,860 |
63,284 |
88,487 |
95,746 |
114,032 |
Depreciation and amortization |
32,319 |
36,194 |
39,969 |
45,938 |
51,875 |
Interest and dividends income |
-2,830 |
-2,955 |
-2,885 |
-3,742 |
-3,346 |
Interest expense |
1,405 |
1,441 |
1,744 |
1,993 |
2,101 |
(Increase) decrease in trade receivables |
12,127 |
-20,852 |
-749 |
-28,444 |
-35,699 |
(Increase) decrease in inventories |
-11,873 |
7,513 |
-5,707 |
-25,709 |
-21,360 |
Increase (decrease) in trade payables |
-15,159 |
-15,881 |
-2,623 |
28,711 |
3,516 |
Increase (decrease) in advances received |
1,557 |
-12,185 |
9,339 |
9,748 |
4,357 |
Other, net |
-171 |
-20,796 |
-26,744 |
13,366 |
-407 |
Subtotal |
61,235 |
35,762 |
100,829 |
137,607 |
115,068 |
Interest and dividends received |
2,830 |
2,959 |
2,847 |
3,679 |
3,438 |
Interest paid |
-1,396 |
-1,416 |
-1,738 |
-1,996 |
-2,166 |
Income taxes paid |
-16,582 |
-10,374 |
-25,129 |
-23,126 |
-31,481 |
Net cash provided by (used in) operating activities |
46,087 |
26,931 |
76,809 |
116,163 |
84,858 |
Cash flows from investing activities: |
Purchase of fixed assets and marketable and investment securities |
-23,338 |
-20,607 |
-34,957 |
-61,293 |
-67,279 |
Proceeds from sale of fixed assets and marketable and investment securities |
9,698 |
49,852 |
21,171 |
20,541 |
12,808 |
Other, net |
-13,981 |
-5,767 |
-8,564 |
-8,746 |
-7,948 |
Net cash provided by (used in) investing activities |
-27,621 |
23,477 |
-22,350 |
-49,498 |
-62,418 |
Free cash flows |
18,466 |
50,408 |
54,458 |
66,665 |
22,439 |
Cash flows from financing activities: |
Increase (decrease) in short-term borrowings, net |
-2,296 |
-2,678 |
-3,592 |
-6,002 |
2,023 |
Increase (decrease) in commercial paper, net |
43,500 |
-51,500 |
- |
- |
36,000 |
Proceeds from long-term debt |
30,126 |
62,165 |
- |
- |
15,000 |
Repayments of long-term debt and redemption of bonds |
-26,663 |
-17,156 |
-4,405 |
-30,330 |
-37,885 |
Other, net |
-27,748 |
-30,350 |
-34,896 |
-40,859 |
-61,005 |
Net cash provided by (used in) financing activities |
16,917 |
-39,520 |
-42,894 |
-77,193 |
-45,867 |
Effect of exchange rate changes on cash and cash equivalents |
-772 |
680 |
4,453 |
3,210 |
4,806 |
Net increase (decrease) in cash and cash equivalents |
34,611 |
11,569 |
16,017 |
-7,318 |
-18,621 |
Cash and cash equivalents at beginning of year |
29,134 |
63,746 |
75,332 |
91,350 |
84,165 |
Cash and cash equivalents of resulting from changes of consolidated subsidiaries |
- |
16 |
- |
- |
- |
Cash and cash equivalents of resulting from mergers with non-consolidated subsidiaries |
- |
- |
- |
132 |
- |
Cash and cash equivalents at end of year |
63,746 |
75,332 |
91,350 |
84,165 |
65,543 |